ISPOR Europe 2025 Home
  • About
    • Registration Information
    • News Center
  • Program
    • Program
    • Plenary Sessions
    • Posters
    • Student Program
    • Learning Formats
    • Program Committee
    • Digital Conference Pass
  • Exhibits & Sponsorship
    • Sponsors
    • Media Partners
    • Exhibitor Directory
  • Photo Gallery
  • Award Winners
large-circle

ISPOR Europe 2025

9 - 12 November

  • Home
  • Events
  • Upcoming Conferences & Events
  • ISPOR Europe 2026
  • Program
  • Paper
  • Healthcare Pathway of a Large Cohort of Patients With Chronic Obstructive Pulmonary Disease During the Last Year of Life

    Sep 9, 2025, 16:22 PM
  • Eliciting Patients' and Clinicians' Preferences on Adjuvant Treatment for HR+/HER2- Early Breast Cancer: Design of a Probabilistic Threshold Technique in Italy

    Sep 9, 2025, 16:22 PM
  • Beyond the Surface: Health Technology Assessment and Reimbursement for Inflammatory or Autoimmune Disorders With Cosmetic and Dermatological Manifestations

    Sep 9, 2025, 16:22 PM
  • Real-World Healthcare Resource Utilization and Related Costs Associated With Bladder Cancer in the Brazilian Private Market

    Sep 9, 2025, 16:22 PM
  • Association Between Objective Response and Overall Survival in BRAF V600e-Mutant Metastatic Colorectal Cancer: An Analysis of the BEACON CRC Trial

    Sep 9, 2025, 16:22 PM
  • The Epidemiology Burden and Management of Chronic Hand Eczema in Adolescents: A Systematic Literature Review

    Sep 9, 2025, 16:22 PM
  • Institutional Trends and Healthcare Resource Utilization in Real-World NMIBC and MIBC Treatment in Germany

    Sep 9, 2025, 16:22 PM
  • External Reference Pricing (ERP) Availability vs. Reimbursement Timelines in Poland and Other European Countries: The Analysis of EURIPID Database

    Sep 9, 2025, 16:22 PM
  • Scaling Responsible Healthcare Data Access With AI-Driven Sensitive Patient Variable Detection

    Sep 9, 2025, 16:22 PM
  • Distributional Cost-Effectiveness Analysis: A Case Study of Obesity

    Sep 9, 2025, 16:22 PM
  • Assessing Stakeholders’ Perceptions of the EU Health Technology Assessment Regulation and Access to Innovative Medicines in Europe and the Netherlands: Challenges, Opportunities, and Recommendations

    Sep 9, 2025, 16:22 PM
  • Multistakeholder Survey on Communication of Uncertainties in Cost-Effectiveness Analysis by the Institute of Clinical and Economic Review

    Sep 9, 2025, 16:22 PM
  • Comparing the Economic Burden in Patients With vs. Without Ehlers-Danlos Syndrome (EDS) Using a Large US Electronic Health Records Database

    Sep 9, 2025, 16:22 PM
  • Healthcare Resource Utilization in Adults with Type 1 Diabetes Who Have a Prior Type 2 Diabetes Misdiagnosis and Recorded HbA1c in a US Managed Care Population

    Sep 9, 2025, 16:22 PM
  • Cost-Effectiveness and Budget Impact of Increasing Peritoneal Dialysis Utilization Among End-Stage Kidney Disease Patients in South Korea

    Sep 9, 2025, 16:22 PM
  • Reliability Test of the Hungarian Versions of the Hypertension Knowledge Test and the QLICD-HY Quality of Life Assessment Questionnaire Among People With High Blood Pressure

    Sep 9, 2025, 16:22 PM
  • Cost-Effectiveness Analysis of Image-Guided Ablation vs. Conventional Ablation in Patients With Recurrent Ventricular Tachycardia: Results From the inEurHeart Trial

    Sep 9, 2025, 16:22 PM
  • Evaluating EU-HTA PICO Exercise Outcomes: Duration of Response and Time to Response in Hepatocellular Carcinoma Using Randomization-Preserving Methods with IMbrave150 Data

    Sep 9, 2025, 16:22 PM
  • Real-World Evidence Study on the Resource Impact of Subcutaneous vs. Intravenous Atezolizumab in an NHS Cancer Center

    Sep 9, 2025, 16:22 PM
  • Analysis of the Fiscal and Socioeconomic Impact of a National Social Program to Support In Vitro Fertilization in Romania: A Generational Accounting Model

    Sep 9, 2025, 16:22 PM
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8 (current)
  • 9
  • 10
  • »
Quick Links

  • About
  • Media Center
  • Exhibits & Sponsorships
  • Contact Us
Policies & Legal

  • Antitrust Compliance
  • Code of Ethics
  • Diversity Policy
  • Funding Statement
  • Legal Disclaimer
  • Privacy Policy

Subscribe

Join ISPOR


ISPOR–The Professional Society for
Health Economics and Outcomes Research

Copyright © 2018 ISPOR. All rights reserved.

International Society for Pharmacoeconomics and Outcomes Research, Inc

Website Design & Development by Matrix Group